Vitamin D and Liver Disease
The liver performs the first hydroxylation of vitamin D — cholecalciferol from skin or diet is converted to 25(OH)D in hepatocytes. Chronic liver disease impairs this conversion, and the resulting deficiency is nearly universal in advanced cirrhosis.
Deficiency in NAFLD and cirrhosis
Cross-sectional studies find 50–70% of adults with non-alcoholic fatty liver disease (NAFLD) are 25(OH)D deficient, and severity correlates with hepatic steatosis grade. Rates climb higher in compensated cirrhosis (~65%) and higher still in decompensated cirrhosis (~90%). Contributing factors: reduced hepatic 25-hydroxylation, fat malabsorption from cholestasis, reduced sun exposure, and poor nutritional intake.
NAFLD supplementation evidence
- Barchetta 2016 — 65 NAFLD adults; 2,000 IU/day for 6 months did NOT reduce hepatic fat by MRI vs placebo, though 25(OH)D and insulin sensitivity improved.
- 2018 Cochrane review — insufficient high-quality evidence that vitamin D reduces liver enzymes or improves histology in NAFLD.
- Correcting deficiency remains reasonable for the general benefits (bone, muscle, immune) even if the liver-specific benefit is modest.
When to switch to calcifediol
In advanced cirrhosis with impaired hepatic 25-hydroxylation, oral cholecalciferol may fail to raise 25(OH)D even at high doses. Calcifediol (already-25-hydroxylated vitamin D) bypasses this step. It's licensed in several European countries and available through specialty pharmacies in the US. Hepatologists use it for transplant candidates and patients with persistent deficiency despite oral cholecalciferol.
Cholestatic disease and fat malabsorption
Primary biliary cholangitis, primary sclerosing cholangitis, and any cause of chronic cholestasis reduce bile flow and impair fat-soluble vitamin absorption (A, D, E, K). These patients need higher doses, water-miscible vitamin D preparations, or IM cholecalciferol. Vitamin K deficiency is a separate concern — clinicians monitor INR and supplement as needed.
Practical guide
- Any chronic liver disease diagnosis: check 25(OH)D at baseline and yearly.
- Correct to at least 30 ng/mL. NAFLD: 2,000–4,000 IU/day cholecalciferol.
- Cirrhosis or cholestasis: higher doses often needed; consider calcifediol if oral cholecalciferol fails.
- Osteopenia/osteoporosis is common — DEXA and appropriate treatment reduce fracture risk.